Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Nitin Butala

Neurology Jacksonville, FL Medical Doctor

NPI 1740483882 CMS profile 34329

841 Prudential Dr Fl 10, Jacksonville, FL 32207

Open in the dashboard

General payments

$15,480

587 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Nitin Butala of Jacksonville, FL is reported in the CMS Open Payments database as having received $15,480 across 587 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $5,503 15
2022 General $3,110 155
2021 General $2,929 181
2020 General $1,986 118
2019 General $1,952 118

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nitin Butala
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Nitin Butala were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Nitin Butala Neurology median Middle half National median
2019 $1,952 $474 $118–$2,177 $163
2020 $1,986 $367 $82–$2,309 $114
2021 $2,929 $438 $104–$2,547 $132
2022 $3,110 $442 $103–$2,388 $149
2023 $5,503 $464 $119–$2,312 $160
2024 $0 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Corium, Inc. $5,310 10 payments
  2. Teva Pharmaceuticals USA, Inc. $918 78 payments
  3. Amgen Inc. $902 42 payments
  4. Allergan Inc. $752 45 payments
  5. AbbVie, Inc. $564 59 payments
  6. Biogen, Inc. $467 29 payments
  7. Genzyme Corporation $426 18 payments
  8. Alexion Pharmaceuticals, Inc. $410 18 payments
  9. Horizon Therapeutics plc $404 11 payments
  10. Eisai Inc. $395 20 payments
  11. Other $4,931 257 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $10,188 578 payments
  2. Consulting Fee $2,500 1 payment
  3. Travel and Lodging $2,481 4 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $226 3 payments
  5. Education $83 1 payment
Products named General payments · program years 2019–2023
  1. ADLARITY $5,310 10 payments
  2. AIMOVIG $1,125 58 payments
  3. UBRELVY Neuroscience $628 38 payments
  4. AJOVY $617 57 payments
  5. Fycompa $395 20 payments
  6. NURTEC ODT $391 18 payments
  7. GOCOVRI $344 20 payments
  8. Briviact $338 13 payments
  9. UBRELVY Neuroscience $314 37 payments
  10. TYSABRI $304 18 payments
  11. Other $5,907 320 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 8 billing codes

Paid by Medicare

$8,557

Medicare's payments for the services billed

Medicare patients

64

Average age 77

Services billed

114

46 women, 18 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 69%
Ischemic heart disease 61%
Chronic kidney disease 50%
Depression 50%
Diabetes 47%
Atrial fibrillation 41%
Alzheimer's or dementia 39%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

587 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record